Glenn Harris, PhD

Director of Business Development and Strategy, Life Sciences at 908 Devices

Glenn has worked at 908 Devices Inc. since 2012 helping to develop and commercialize the first hand-held mass spectrometry platform. As one of the first company hires, he has led several critical integration efforts of sampling and ionization approaches to the mass spectrometry platform for safety and security, forensics, petroleum, and life sciences fields. Currently, Glenn directs the business and technical development of the new integrated life sciences platform called the REBEL. The REBEL is an at-line bioprocess analyzer which quantitates more than 30 nutrients like amino acids and vitamins in minutes from cell culture media with minuscule sample volume requirements. Prior to joining 908 Devices, Glenn received his PhD in Analytical Chemistry from the Georgia Institute of Technology and had a post-doctoral fellowship at the Vanderbilt University Medical Center.